Healthy people.
Conditions
Interventions
Intervention 1: Intervention group 1: We will use LASER Lumix3 instrument with 808nm wavelength, continuous waves, circle cross section (3.14cm2), PD=250mw/cm2, ED=60J/cm2. LASER applicator will conta
Treatment - Devices
Intervention group 1: We will use LASER Lumix3 instrument with 808nm wavelength, continuous waves, circle cross section (3.14cm2), PD=250mw/cm2, ED=60J/cm2. LASER applicator will contact with particip
Intervention group 2: We will use LASER Lumix3 instrument with 808nm wavelength, continuous waves, circle cross section (3.14cm2), PD=250mw/cm2, ED=60J/cm2. LASER applicator will contact with particip
Control group 1: The usage protocol and LASER instrument is similar to first intervention group. Main difference is placing a LASER filter between applicator and participants' skin that prevent from L
Control group 2: The usage protocol and LASER instrument is similar to first intervention group. Main difference is placing a LASER filter between applicator and participants' skin that prevent from L
Sponsors
?????? ?????? ??????? ???? ????? ?????
Eligibility
Sex/Gender
All
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Right-handedness 18-30 years old
Exclusion criteria
Exclusion criteria: Uncorrected visual impairment Upper extremity neurologic or orthopedic disorders Sleep disorder Left handedness pregnancy History of epilepsy Having a regular manual activity involving high dexterity (such as playing the piano) Taking medication affecting the neural system History of neurological or psychological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of taps in Finger tapping test. Timepoint: Measurement the number of taps in Finger tapping test immediately before and after transcranial light therapy. Method of measurement: Computer Software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Fekri Sustani
Tabriz University of Medical Sciences
Outcome results
None listed